TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vida Världen Vaccin AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
354
|
247
|
161 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
-4
|
4
|
-4 |
EBITDA |
-3
|
4
|
-4 |
Total assets |
89
|
81
|
109 |
Current assets |
89
|
81
|
109 |
Current liabilities |
22
|
9
|
6 |
Equity capital |
68
|
72
|
103 |
- share capital |
5
|
4
|
5 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
76.4%
|
88.9%
|
94.5% |
Turnover per employee |
177
|
124
|
80 |
Profit as a percentage of turnover |
-1.1%
|
1.6%
|
-2.5% |
Return on assets (ROA) |
-3.4%
|
4.9%
|
-3.7% |
Current ratio |
404.5%
|
900%
|
1816.7% |
Return on equity (ROE) |
-5.9%
|
5.6%
|
-3.9% |
Change turnover |
107
|
99
|
-62 |
Change turnover % |
43%
|
67%
|
-28% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.